miR-139-5p Represses BMSC Osteogenesis via Targeting Wnt/β-Catenin Signaling Pathway

Area of Science:

• Biomedical Engineering
• Cell Biology
• Regenerative Medicine

Background:

• Mesenchymal stem cells (MSCs) are crucial for bone repair.
• MicroRNAs regulate cellular functions, including differentiation.
• The role of miR-139-5p in human bone marrow MSC (hBMSC) osteogenesis requires investigation.

Purpose of the Study:

• To investigate the function of miR-139-5p in hBMSC osteogenic differentiation.
• To explore the underlying molecular mechanisms of miR-139-5p's action.

Main Methods:

• Assessed alkaline phosphatase (ALP) activity and alizarin red S (ARS) staining for osteogenic markers.
• Quantified the expression of key osteogenic genes: Runx2, Col-1, and OCN.
• Investigated the effect of miR-139-5p inhibition and overexpression on hBMSC differentiation.
• Analyzed the potential involvement of the Wnt/β-catenin pathway by targeting CTNNB1 and FZD4.

Main Results:

• Inhibiting miR-139-5p significantly promoted hBMSC osteogenic differentiation.
• Overexpression of miR-139-5p reduced osteogenic differentiation.
• Changes in ALP activity, ARS staining, and osteogenic gene expression confirmed these findings.
• miR-139-5p likely regulates osteogenesis by targeting CTNNB1 and FZD4 within the Wnt/β-catenin pathway.

Conclusions:

• miR-139-5p acts as a negative regulator of hBMSC osteogenic differentiation.
• Inhibiting miR-139-5p enhances osteogenesis, offering a potential therapeutic strategy for bone regeneration.
• Targeting miR-139-5p may be a promising approach for bone defect repair.